Corporate Finance

China's Atom Therapeutics is advancing a dual-threat pipeline, with novel drugs for gout and a groundbreaking anti-inflammatory aimed at cardiovascular disease.

With the 2026 World Cup looming, Men in Blazers partners with NFQ Technologies to build a central digital hub, aiming to turn fleeting attention into lasting loyalty.

Syngenta joins India's ambitious Annam.AI, promising a digital future for farmers. But is this a benevolent tech leap or a strategic data grab?

Beneath resilient spending figures lies a seismic shift. Consumers are trading volume for value, forcing brands to rethink survival in an age of intention.

Orange is overhauling its debt with new hybrid notes. The move is more than financial housekeeping—it’s a strategic play to fund its global ambitions.

With exploration complete, new state laws in place, and a fortified land position, Pulsar Helium is fast-tracking its Topaz project to production.

Susan Solomon’s Tang Prize is more than an award; it's a tale of how science can save us, and a stark reminder of the irreversible challenges ahead.

Marriott's luxury brand EDITION is launching a mini-drama in China. We analyze why this signals a major shift from selling rooms to selling narratives.

With a fresh €1 billion from an oversubscribed bond sale, the French tech giant is doubling down on its vision to reshape industries with AI-powered virtual twins.

Wonga SA's top tech award signals a new era for short-term lending, using AI and alternative data to champion financial inclusion for millions in South Africa.

While ComEd’s massive storm response is a logistical victory, it serves as a stark preview of the multi-billion-dollar price tag for grid resilience.

A new BCG report reveals a dangerous gap: 96% of CMOs see AI as transformative, but only 8% use it autonomously. The race is on to close this divide.

With demand for AI compute outpacing supply, a new partnership aims to deliver purpose-built infrastructure across South Korea on an accelerated timeline.

HashKey Holdings plans a HKD100M share buyback, signaling deep confidence in its Web3 strategy despite a slumping stock price. What does this mean for investors?

Atossa Therapeutics secures a crucial capital lifeline. We dissect the deal, its impact on a promising cancer drug, and what it reveals about biotech funding today.

With a high-yield dividend and perfect rent collection, NewLake Capital signals stability. But is this cannabis REIT a safe haven or just a high-risk reward?

A $262,500 grant for a music festival seems simple, but it's an investment in a complex system. We explore how public funds fuel Montréal's cultural identity, economic vitality, and a greener future.

Cincinnati's baseball team partners with Avocados From Peru in a strategic play that goes beyond the ballpark, blending experiential marketing with healthy eating.

An $85M loan greenlights Beverly Hills' largest residential complex. But the real story is a decade of struggle, a key state law, and a city's future.

Australian biotech Gelteq has a gel that makes bitter medicine taste good to dogs. It's more than a pet owner's dream—it's a strategic move in a $47B market.